Jennifer A. Maynard, Ph.D.
Affiliations: | 2001 | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
discovery and development of protein therapeutics and applied immunology by capitalizing on state of the art protein engineering, directed evolution and systems biology technologiesGoogle:
"Jennifer Maynard"Mean distance: 11.06
Parents
Sign in to add mentorGeorge Georgiou | grad student | 2001 | UT Austin | |
(Engineering antibody therapeutics: Approaches to neutralizing bacterial toxins.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Siles N, Schuler M, Maguire C, et al. (2023) SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics. Medrxiv : the Preprint Server For Health Sciences |
Maynard JA, Segatori L. (2023) Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologies. Current Opinion in Biotechnology. 83: 102981 |
Silva RP, Huang Y, Nguyen AW, et al. (2023) Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses. Elife. 12 |
Qerqez AN, Silva RP, Maynard JA. (2023) Outsmarting Pathogens with Antibody Engineering. Annual Review of Chemical and Biomolecular Engineering |
Bowen JE, Park YJ, Stewart C, et al. (2022) SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Science Immunology. eadf1421 |
Liu Y, Nguyen AW, Maynard JA. (2022) Engineering antibodies for conditional activity in the solid tumor microenvironment. Current Opinion in Biotechnology. 78: 102809 |
Goldsmith JA, DiVenere AM, Maynard JA, et al. (2022) Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin. Cell Reports. 40: 111196 |
DiVenere AM, Amengor D, Silva RP, et al. (2022) Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis. Mbio. e0152722 |
Liu Y, Lee AG, Nguyen AW, et al. (2022) An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH using mammalian cell display. The Journal of Biological Chemistry. 101798 |
Costello SM, Shoemaker SR, Hobbs HT, et al. (2022) The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes. Nature Structural & Molecular Biology |